These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Morphological detection algorithms for the automatic implantable cardioverter/defibrillator (AICD). Kaup HJ; Hexamer M; Werner J Biomed Tech (Berl); 2004 Nov; 49(11):306-10. PubMed ID: 15624867 [TBL] [Abstract][Full Text] [Related]
30. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. Tung R; Zimetbaum P; Josephson ME J Am Coll Cardiol; 2008 Sep; 52(14):1111-21. PubMed ID: 18804736 [TBL] [Abstract][Full Text] [Related]
31. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study. Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108 [TBL] [Abstract][Full Text] [Related]
32. Near fatal arrhythmia induction by an implantable cardioverter defibrillator. Wollmann CG; Göttker U; Böcker D; Gradaus R J Cardiovasc Electrophysiol; 2006 Sep; 17(9):1026-8. PubMed ID: 16764706 [TBL] [Abstract][Full Text] [Related]
33. Implantable cardioverter-defibrillator lead failure: how weak is the link? Brinker JA Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):758-9. PubMed ID: 18838965 [TBL] [Abstract][Full Text] [Related]
34. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy. Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314 [TBL] [Abstract][Full Text] [Related]
35. Automatic home monitoring of implantable cardioverter defibrillators. Nielsen JC; Kottkamp H; Zabel M; Aliot E; Kreutzer U; Bauer A; Schuchert A; Neuser H; Schumacher B; Schmidinger H; Stix G; Clémenty J; Danilovic D; Hindricks G Europace; 2008 Jun; 10(6):729-35. PubMed ID: 18434298 [TBL] [Abstract][Full Text] [Related]
36. Effects of an alert system on implantable cardioverter defibrillator-related anxiety: rationale, design, and endpoints of the PANORAMIC multicentre trial. Duru F; Dorian P; Favale S; Perings C; Pedersen SS; Willems V; Europace; 2010 May; 12(5):726-30. PubMed ID: 20207746 [TBL] [Abstract][Full Text] [Related]
37. [The use of implantable cardioverter-defibrillators (ICD) in children and adolescents]. Apitz C; Gass M; Dörnberger V; Kuehlkamp V; Hofbeck M Klin Padiatr; 2006; 218(5):270-5. PubMed ID: 16947095 [TBL] [Abstract][Full Text] [Related]
38. Twisting until it breaks: a rare cause of ICD lead failure. Budzikowski AS; Uyguanco E; Gunsburg MY; Kassotis J Cardiol J; 2008; 15(6):558-60. PubMed ID: 19039762 [TBL] [Abstract][Full Text] [Related]
39. Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs. Singh S; Murawski MM J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):175-80. PubMed ID: 17875944 [TBL] [Abstract][Full Text] [Related]
40. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Proclemer A; Ghidina M J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]